ArticlePloS one2026
Evaluation of a home pharmaceutical care service model for home-based patients receiving anticoagulation therapy within county-level medical community.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo establish a systematic, standardized, and operational model of home pharmaceutical care for patients with anticoagulant treatment in county-level medical community.
methodsA home pharmaceutical care service team was constituted by pharmacists and physicians from the county-level medical community. A home-based pharmaceutical care survey was conducted for patients with long-term oral anticoagulants (VKAs, rivaroxaban, dabigatran and apixaban). The patients' awareness and adherence score to oral anticoagulants(OATs) was evaluated before and after home pharmaceutical care service. The awareness and adherence score were evaluated with awareness questionnaires and Morisky Medication Adherence Scale-8 (MMAS-8), respectively. The paired-sample t tests were used to compare the awareness and adherence score.
resultsFinally, totally 95 patients completed the survey. Among these patients, 29 patients were in the VKAs group and 66 patients were in the NOACs group. Following the implementation of home pharmaceutical care service, there was an increase in the awareness score, rising from 5.02 ± 1.71 to 8.09 ± 1.25 (p < 0.001). Similarly, the adherence score increased from 4.66 ± 1.66 to 6.94 ± 0.59 (p < 0.001).
conclusionsThis pilot study demonstrates that the home pharmaceutical care service model implemented within county-level medical community for anticoagulation treatment is feasible and shows promise in improving anticoagulation knowledge and medication adherence among patients.The findings provide preliminary evidence for a service model that could be further evaluated. Future controlled studies are warranted to confirm its efficacy and to investigate its impact on clinical health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.